CBX3 and familial pancreatic carcinoma: We divided patients with pancreatic cancer into three groups: current smokers, former smokers, and never smokers, and found that CBX3 was markedly increased in current smokers (P < 0.05; Fig. 1B and Fig. S1A-G).